Scientists have made an important discovery that could change the way doctors understand and treat Alzheimer’s disease.
For many years, researchers have focused mainly on two harmful proteins in the brain called amyloid and tau.
These proteins build up into abnormal clumps that damage brain cells and have long been considered the main cause of memory loss in people with Alzheimer’s disease.
However, a new study suggests that another process inside the brain may play an equally important role, especially in causing the emotional and behavioral symptoms that many patients experience. The research was published in JAMA Network Open by scientists at the University of Pittsburgh School of Medicine.
Alzheimer’s disease is the most common cause of dementia. It slowly destroys brain cells, leading to memory loss, confusion, difficulty thinking, and problems carrying out everyday tasks.
While memory problems are the best-known sign of Alzheimer’s disease, many people also develop depression, anxiety, irritability, mood swings, agitation, sleep problems, and changes in personality. These symptoms can appear early in the illness and often become one of the hardest parts of the disease for both patients and their families.
Doctors have struggled to treat these emotional and behavioral symptoms because the exact cause has never been fully understood. The new study points to inflammation in the brain as a possible answer.
Inflammation is the body’s natural response to injury or infection. It helps protect the body and repair damage. However, when inflammation continues for too long, it can begin to damage healthy tissue. The brain has its own immune cells, called microglia. These cells constantly watch for infections, injuries, and damaged brain cells.
When needed, they become active and help protect the brain. But if they stay active for too long, they can create ongoing inflammation that may harm brain cells instead of helping them.
The University of Pittsburgh team had already suggested in earlier research that brain inflammation, also called neuroinflammation, might be an important part of Alzheimer’s disease. In this new study, they gathered stronger evidence linking this inflammation directly to the emotional and behavioral problems experienced by patients.
The researchers studied 109 older adults. Most of them did not yet have clear memory problems, but brain scans showed that many already had amyloid and tau proteins building up in their brains. The scientists used advanced brain imaging to measure microglial activation, which shows how active the brain’s immune cells had become.
The results were clear. People with higher levels of microglial activation were much more likely to experience depression, anxiety, sleep problems, agitation, irritability, and rapid mood changes. Caregivers also reported more emotional outbursts and difficult behaviors in participants who had higher levels of brain inflammation.
Lead author Dr. Cristiano Aguzzoli said these findings help explain why these symptoms develop so early in Alzheimer’s disease. Instead of being caused only by amyloid and tau, they may be strongly influenced by inflammation inside the brain.
The discovery could lead to new treatment options. Most current Alzheimer’s medicines are designed to reduce amyloid or slow disease progression. If future studies confirm these findings, doctors may also be able to target brain inflammation.
Medicines that calm overactive microglia or reduce harmful inflammation might improve mood, sleep, anxiety, and behavior, making daily life easier for patients and reducing stress on caregivers.
Senior author Dr. Tharick Pascoal and his colleagues also believe these findings may extend beyond Alzheimer’s disease. Other brain disorders, including Parkinson’s disease dementia and related conditions, also involve inflammation and similar emotional symptoms.
The team plans to work with researchers around the world to investigate whether reducing brain inflammation could benefit people with several different forms of dementia.
Although this study cannot prove that inflammation directly causes these symptoms, it provides strong evidence that the two are closely connected. Larger studies and clinical trials will now be needed to determine whether anti-inflammatory treatments can safely improve patients’ quality of life.
This research reminds us that Alzheimer’s disease is much more than memory loss. Emotional health, behavior, and sleep are also deeply affected.
By understanding how the brain’s immune system contributes to these changes, scientists may be opening the door to more effective treatments that improve not only memory but also everyday well-being for patients and their families.
If you care about Alzheimer’s disease, please read studies that bad lifestyle habits can cause Alzheimer’s disease, and strawberries can be good defence against Alzheimer’s.
For more information about brain health, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
